RxDoctor Payments Data

Renai Allen, APRN

Psychiatric/Mental Health · Alpharetta, GANPI 1790872158

Payments from drug & device makers

$321in general payments, 2019–2025

Across 16 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$85
  • Otsuka America Pharmaceutical, Inc.$60
  • Alkermes, Inc.$60
  • Johnson & Johnson$37
  • Corium, LLC$30
  • Neos Therapeutics, LP$17
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$321100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$321 in reported general payments places this provider in the 45th percentile of 900 psychiatric/mental health providers in Georgia.

See all psychiatric/mental health providers in Georgia

Medicare billing

Part B allowed, 2024
$9,331
Medicare patients
66
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl81$106,151
LybalviOlanzapine/Samidorphan Malate47$75,646
Invega SustennaPaliperidone Palmitate18$55,771
RexultiBrexpiprazole37$53,061
AristadaAripiprazole Lauroxil15$48,833
Abilify MaintenaAripiprazole15$35,958
VivitrolNaltrexone Microspheres13$23,192
Aripiprazole OdtAripiprazole42$20,429
Aripiprazole127$15,649
Lamotrigine275$7,850
Quetiapine Fumarate176$7,815
Paliperidone ErPaliperidone41$6,678
Clozapine106$6,497
Olanzapine99$5,513
Quetiapine Fumarate ErQuetiapine Fumarate44$4,358

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi, Aristada, Vivitrol$60$147,67175 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$60$89,01952 claims
Johnson & JohnsonInvega Sustenna$37$55,77118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 900 psychiatric/mental health providers in Georgia.

Other psychiatric/mental health in Alpharetta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →